TIMP1 and pancreatic neoplasm: To investigate that whether TIMP-1 could reduce pancreatic cancer cell migration, exogenous recombinant TIMP-1 was added to the culture medium of poorly differentiated PANC-1 cells at common concentrations of 50, 100 ng/mL [6, 26], followed by a wound closure assay.